PUBLICATIONS

Filter by year:

Benefit evaluation in multiple sclerosis relapse treatment from the patients' perspective - development and validation of a new questionnaire

Beckmann H, Augustin M, Heesen C, Poettgen J, Blome C

Publication year:2019
Journal:Mult Scler Relat Disord 28:256-61
PMID:
30639826
DOI:
10.1016/j.msard.2018.12.021

Willingness to pay for a cure of low-risk melanoma patients in Germany

Augustin M, Blome C, Forschner A, Gutzmer R, Hauschild A, Heinzerling L, Livingstone E, Loquai C, Schadendorf D, Utikal J, Wagner T, Wilden S, Kähler KC

Publication year:2018
Journal:PLOS ONE 24;13(5):e0197780
PMID:
29795621
DOI:
10.1371/journal.pone.0197780

Fear of cancer progression in patients with stage IA malignant melanoma

Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, Heinzerling L, Livingstone E, Loquai C, Schadendorf D, Terheyden P, Mueller-Brenne T, Kähler KC

Publication year:2018
Journal:Eur J Cancer Care 27(5):e12901
PMID:
30126009
DOI:
10.1111/ecc.12901

Differences between Patient- and Proxy-reported HRQoL Using the Wound-QoL

Sommer R, Hampel-Kalthoff C, Kalthoff B, Neht C, Scherfer E, Winkler M, Blome C

Publication year:2018
Journal:Wound Repair Regen 26(3):293-6
PMID:
30118159
DOI:
10.1111/wrr.12662

Development and validation of the Patient Benefit Index for peripheral arterial disease

Zander N, Demirel EB, Augustin M, Sommer R, Debus ES, Breuer P, Blome C

Publication year:2018
Journal:VASA 47(3):219-26
PMID:
29366378
DOI:
10.1024/0301-1526/a000687

Validation of a short form FLQA-LS quality of life instrument for lymphedema

Augustin M, Conde Montero E, Hagenström K, Herberger K, Blome C

Publication year:2018
Journal:Br J Dermatol 31(4):257-63
PMID:
29927481
DOI:
10.1111/bjd.16902

The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians

Kähler KC, Blome C, Forschner A, Gutzmer R, Hauschild A, Heinzerling L, Livingstone E, Loquai C, Müller-Brenne T, Schadendorf D, Utikal J, Wagner T, Augustin M

Publication year:2018
Journal:Oncotarget 25;9(40):26217-25
PMID:
29899854
DOI:
10.18632/oncotarget.25439

Measuring the importance of health domains in psoriasis discrete choice experiment versus rating scales

Gutknecht M, Schaarschmidt ML, Danner M, Blome C, Augustin M

Publication year:2018
Journal:Patient Prefer Adherence 15;12:363-73
PMID:
29588575
DOI:
10.2147/PPA.S152509

Efficacy of a N-palmitoylethanolamine containing bodylotion in subjects with chronic pruritus due to dry skin: results of a dermatocosmetic study

Viß K, Blome C, Phan NQ, Augustin M, Ständer S

Publication year:2017
Journal:Acta Derm Venereol 97(5):639-41
PMID:
27983740
DOI:
10.2340/00015555-2593

Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis

Augustin M, Blome C, Paul C, Puig L, Luger T, Lambert J, Chimenti S, Girolomoni G, Kragballe K, Naessens D, Bergmans P, Smirnov P, Barker J, Reich K

Publication year:2017
Journal:J Eur Acad Dermatol Venereol 31(2):294-303
PMID:
27515070
DOI:
10.1111/jdv.13823
<< < 1 … 5 6 7 8 9 … 14 > >>